Background-We sought to evaluate the safety and feasibility of a minimally fluoroscopic approach using the CARTOUNIVU module during scar-related ventricular tachycardia (VT) ablation. Methods and Results-Consecutive patients with structural heart disease undergoing VT ablation using the CARTOUNIVU module were prospectively included and classified depending on their VT substrate: (1) ischemic VT (IVT) and (2) nonischemic VT and depending on the presence of an epicardial access. Radiation exposure parameters and major and minor procedure-related complications were registered. A near-zero fluoroscopy exposure was defined as those procedures with an effective dose ≤1 mSv. A total of 44 VT ablation procedures were performed in 41 patients ( 
V entricular tachycardia (VT) ablation in patients with structural heart disease is one of the most challenging procedures currently performed in an electrophysiology laboratory. As a result, fluoroscopy times and doses are usually prolonged even in the most experienced hands. 1, 2 During the past years, electroanatomical mapping systems have facilitated catheter navigation and have helped in reducing radiation exposure in this setting. 3, 4 However, fluoroscopy still remains as the cornerstone for assessing the real catheter position and movement, as well as for certain parts of the procedure, such as transseptal puncture and epicardial access. A minimally fluoroscopic approach would be desirable in this context but has never been explored.
Recently, a new image integration tool, the CARTOUNIVU module, has been incorporated into the CARTO navigation system and has demonstrated a significant reduction of fluoroscopy times and doses in small series. [5] [6] [7] Different arrhythmia substrates have been evaluated in these studies, including a limited number of patients undergoing VT ablation. 8 However, the utility of the CARTOUNIVU module during VT ablation has not been yet systematically evaluated in large series.
The aim of our study was to evaluate the safety and utility of the CARTOUNIVU module in patients with structural heart disease undergoing VT ablation and to analyze the influence of the different VT substrates on the benefits of this image integration tool.
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Óscar Cano, MD, PhD; Ana Andrés, MD; Joaquín Osca, MD, PhD; Pau Alonso, MD; María-José Sancho-Tello, MD; José Olagüe, MD; Luis Martínez-Dolz, MD, PhD presence of left ventricular (LV) hypertrophy >15 mm, LV ejection fraction <50%, mechanical or biological prosthetic valve, valvulopathy of at least moderate grade, previous myocardial infarction, significant coronary artery disease, or the presence of a primary myocardial disease. Patients were classified depending on the VT substrate in 2 groups: (1) ischemic VT (IVT), including all patients with previous myocardial infarction or documented significant coronary artery disease; and (2) nonischemic VT (NIVT), including all other VT substrates. Patients were also classified based on the need of an epicardial access for mapping and ablation during the procedure.
Patients were brought to the laboratory in the fasting state, and all the procedures were performed either under general anesthesia or under conscious sedation obtained by propofol infusion and fentanyl boluses. If present, oral anticoagulation was withheld 3 to 5 days before the procedure, and patients received heparin bridging. This study was carried out following the institutional guidelines of the Hospital Universitari i Politècnic La Fe and was approved by the ethics committee, and all patients gave informed written consent.
Description of the UNIVU Image Integration Module
The CARTOUNIVU module has been previously described elsewhere. [5] [6] [7] [8] Briefly, the module allows the integration of fluoroscopy images into the electroanatomic mapping system after an initial simple registration process. Once the registration process has been performed, the operator is allowed to acquire either static or cine fluoroscopy images in different projections that will be automatically transferred to the mapping system at any time during the procedure. Multiple fluoroscopic projections are usually obtained in standard angulations, and the electroanatomical map can be created on top of the acquired fluoroscopic images, thus aiming for a reduction of fluoroscopy levels and minimizing radiation exposure for physicians, staff, and patients. In patients with epicardial VT circuits, the CARTOUNIVU module allows the integration of the real-time coronary angiography performed during the procedure into the electroanatomic mapping system to minimize the risk of injury of the coronary arteries during epicardial ablation.
Procedure Workflow
The same systematic approach was used in all patients. Initially, 2 or 3 venous and 1 arterial femoral accesses were obtained. Usually, a single quadripolar catheter and a decapolar catheter were placed at the right ventricular (RV) apex and coronary sinus, respectively. LV endocardial mapping was systematically performed by transseptal access. Retrograde aortic access was also used at the discretion of the operator during the procedure. Computed tomography (CT) or magnetic resonance imaging integration within the CARTO system was not used in any patient.
After gaining vascular access, the registration process was performed to be able to integrate the fluoroscopy images into the electroanatomic mapping system. Then, standard anteroposterior, 35° to 40° left anterior oblique and 25° to 30° right anterior oblique cine loops were acquired. A 4-mm tip, open-irrigated ablation catheter with contact force measurement capabilities (Smart-Touch; Biosense Webster, Diamond Bar, CA) was introduced through one of the venous sheaths. An electroanatomical reconstruction of the right atrium and coronary sinus was initially performed in all patients on top of 2 orthogonal fluoroscopic views (usually right anterior oblique at 25°-30° and left anterior oblique at 35°-40°) previously captured by the CARTOUNIVU module and displayed in the map viewer. The electroanatomic reconstruction of the right atrium and coronary sinus served as a guidance to place the diagnostic catheters without the need of fluoroscopy.
Patients with a clinical VT suspected of being of epicardial origin underwent epicardial access immediately after diagnostic catheter placement. Using the technique described by Sosa et al, 9 a 0.32-mm J-shaped wire was introduced in the pericardial space with fluoroscopy guidance and was left in place for an eventual epicardial mapping/ablation. Thereupon, an endocardial RV voltage mapping was performed in those patients with suspicion of VT originating from the RV. Otherwise, a fluoroscopy-guided transseptal puncture was used to gain access to the LV. After left cardiac chambers were accessed, an initial 80 IU/kg IV heparin bolus and repeated doses of 1000 IU every hour during the procedure were administered.
A detailed LV endocardial voltage map was obtained during the patient's basal rhythm. Standard values were used to define the LV endocardial scar and the border zone as previously described (<0.5 and 1.5 V, respectively). 10 At this point, the epicardial map was performed in those patients with epicardial access. After completion of the endocardial or epicardial voltage mapping, programmed ventricular stimulation was used to induce VT. Up to 3 extrastimuli from either the right or the LV were administered for a basal drive train of 600 to 400 ms. If a stable and hemodynamically well-tolerated VT was induced, activation and entrainment mapping was used to delineate the VT circuit and to identify critical isthmuses. In the case of hemodynamic instability or noninducible patients, a substrate-based ablation was planned. Pacemapping was also used whenever a 12-lead ECG of the clinical VT was available. Radiofrequency lesions were applied using a temperature control mode with a targeted temperature of 40°C at 40 to 50 W during 30 to 60 s in the endocardium (cool flow, 30 mL/h) and at 30 to 40 W in the epicardium (cool flow, 5 mL/h).
Evaluation of Radiation Exposure and Procedure Times
Three parameters were used to evaluate radiation exposure: the cumulative air kerma expressed in cGy, the total dose area product (tDAP) expressed in cGy per cm 2 , and the effective dose (ED) expressed in mSv. The cumulative air kerma and the tDAP were used as indicators of cumulative radiation exposure. Air kerma is used to express
WHAT IS KNOWN
• Radiation exposure is a matter of concern during complex arrhythmia ablation procedures, such as ventricular tachycardia (VT) ablation. Prolonged fluoroscopy times and doses have been traditionally reported during VT ablation even in the most experienced hands.
• New image integration tools have recently shown to be effective in reducing fluoroscopy levels and minimizing radiation exposure for physicians, staff, and patients in small series of patients undergoing VT ablation. However, a minimally fluoroscopic approach has been never explored in this setting.
WHAT THE STUDY ADDS
• The use of the CARTOUNIVU module in a consecutive large series of patients undergoing scar-related VT ablation resulted in low levels of radiation exposure.
• The VT substrate has a significant influence in the levels of radiation exposure, with nonischemic VT ablation procedures showing higher levels of radiation exposure.
• A minimally fluoroscopic approach is possible during scar-related VT ablation in ≈50% of patients, especially among those who only need endocardial access and those with ischemic VT. the radiation concentration delivered to a particular point, such as the entrance surface of a patient's body. The tDAP is the product of the air kerma and the exposed area in cm 2 and is considered a good estimation of the total radiation energy delivered to a patient during a procedure. The ED was estimated using the following formulae: ED (mSv)=tDAP (Gy cm 2 )×0.2 (mSv/Gy cm 2 ). 3 The total procedure time was considered from the vascular access to sheath removal. The total fluoroscopy time (TFT) expressed in minutes, and the fluoroscopy and procedure times used for every step during the ablation procedure were also evaluated.
Study End Points
The primary objective of the study was to evaluate the utility of the CARTOUNIVU module in patients undergoing VT ablation in the setting of structural heart disease. The utility of the image integration module was evaluated by the measurement of fluoroscopy data, including TFT and doses (cumulative air kerma, tDAP, and ED), as well as total procedure time both in the entire population sample and in the subgroups created depending on the VT substrate and on the presence of an epicardial access. To determine the feasibility of a minimally fluoroscopic approach during VT ablation procedures, we arbitrarily defined a near-zero fluoroscopy exposure as those procedures with an ED of ≤1 mSv.
The secondary end points of the study included the evaluation of the safety of the CARTOUNIVU module during VT ablation. Thus, major and minor complications related to the procedure were registered. Finally, we also evaluated the utility of the integration of the real-time coronarography into the electroanatomic mapping system in patients undergoing epicardial VT ablation.
Ablation Outcomes and Follow-Up
After ablation, programmed ventricular stimulation was performed, and the recommendations of the latest guidelines were used to define the ablation outcomes.
11 Acute complete success was considered when complete elimination of all clinical and nonclinical VTs was obtained. Acute partial success was defined as ablation of the clinical VT only.
Most of the patients included in the study had an implantable cardioverter-defibrillator±cardiac resynchronization therapy device before ablation, and the rest of the patients underwent implantation of an implantable cardioverter-defibrillator after the VT ablation procedure. Thus, patient follow-up was performed at the implantable cardioverter-defibrillator outpatient clinic through the interrogation of the device.
Statistical Analysis
Mean values and SDs are reported for continuous variables with normal distribution. Median and first (Q1) and third (Q3) quartiles were used in the case of variables with skewed distribution with Q1 and Q3 representing the 25th and 75th percentiles, respectively. For categorical variables, absolute frequencies are used. The Student t test, Mann-Whitney U test, χ 2 test, and Fisher exact test were used to compare differences across different patient subgroups. A 2-sided αvalue of <0.05 was considered statistically significant. All analyses were performed by using SPSS (IBM SPSS Statistics, Version 22.0, Armonk, NY).
Results
A total of 44 VT ablation procedures were performed using the CARTOUNIVU module in 41 consecutive patients (mean age, 62±13 years; 39 men) from April 2014 to September 2015 and were included in the study. Twenty-two patients (54%) had IVT, and 19 patients (46%) had an NIVT. Patients with an NIVT included 12 subjects with idiopathic dilated cardiomyopathy, 3 patients with valvular cardiomyopathy, 2 patients with RV cardiomyopathy/dysplasia, and 2 patients with VT in the setting of surgically repaired tetralogy of Fallot. Three patients underwent a second ablation procedure because of clinical recurrence of the VT during follow-up. Endocardial ablation in the LV was performed in 29 patients, and 4 patients were ablated in the endocardial RV. An epicardial access was attempted in a total of 16 of 44 procedures (36%) and was finally achieved in 15 of 16 attempts (2 patients with IVT, 11 patients with idiopathic dilated cardiomyopathy, 1 patient with RV cardiomyopathy/dysplasia, and 1 patient with valvular cardiomyopathy). Epicardial mapping was completed in 14 of 16 patients, 5 patients had an epicardial ablation, and 2 patients were ablated both at the endocardial and epicardial surfaces. In all 7 patients with epicardial ablation, a real-time coronarography was performed before radiofrequency lesions were applied and was integrated into the map viewer to guide radiofrequency applications. Baseline characteristics of the patients are detailed in Table 1 , and procedure-related parameters are presented in Table 2 .
Radiation Exposure and Influence of the VT Substrate
The median TFT in the entire population sample was 6.08 (1.51-12.36) minutes with a median ED of 2.15 (0.58-8.22) mSv (Table 3 ). The mean total procedure time was 204±61 minutes. In a total of 14 of 44 procedures (32%), a near-zero fluoroscopy procedure could be performed showing an ED of ≤1 mSv.
When considering patients according to their VT substrate, patients with IVT showed significant lower radiation exposure parameters when compared with those with NIVT (2.53 [1. 22-11.22 Figure 1 ; Table 3 ). The possibility of performing a near-zero fluoroscopy procedure also depended on the VT substrate with 43% (10/23) of the IVT patients showing an ED of <1 mSv (Figure 2 ). The remaining 4 patients with an ED of <1 mSv included 2 patients with repaired tetralogy of Fallot, 1 patient with valvular cardiomyopathy, and 1 with idiopathic dilated cardiomyopathy. The total procedure time was not influenced by the VT substrate (193±62 minutes for IVT patients versus 217±59 minutes for NIVT patients; P=0. 19) .
The influence of the learning curve in the use of the new image integration module during VT ablation was evaluated by comparing the first 10 patients included in our series with the last 10 patients independently of their VT substrate or the presence of endocardial/epicardial access. The median TFT was significantly higher for the first 10 patients (12.25 [13.11-17.84 
Patients With Epicardial Access
All the radiation exposure parameters were significantly prolonged in patients with an epicardial access. Thus, the median TFT was 14.07 (7.76-24.01) minutes for patients with endocardial/epicardial access versus 2.50 (0.58-7.03) minutes for those with endocardial access only (P<0.0001; Figure  3 ). All patients with an epicardial access had an ED of >5 mSv and significantly prolonged procedures (240±43 versus 185±61 minutes; P=0.003). When considering only procedures with no epicardial access, a near-zero fluoroscopy procedure (ED<1 mSv) could be achieved in 50% of those patients (14/28 procedures). The fluoroscopy time used during the epicardial access and during the coronarography performed before the epicardial ablation represented 37% and 18.8%, respectively, of their TFT.
The coronary angiogram performed before ablation could be integrated into the electroanatomic mapping system in all 7 patients who underwent epicardial ablation and served as a guidance to avoid injury to the coronary vessels (Figure 4) . Radiofrequency delivery was hampered by the presence of a circumflex branch in only 1 of 7 patients who had an epicardial scar located in the lateral LV wall. Lesions were applied around the coronary vessel with a safety distance of 10 mm, and after completing the substrate ablation, the patient was no longer inducible. No single patient experienced a complication related to epicardial VT ablation.
Fluoroscopy Times During Transseptal Puncture, Mapping, and Ablation
The median fluoroscopy time used during each step of the VT ablation procedure was also investigated. In the 40 ablation procedures with endocardial LV mapping/ablation, the median fluoroscopy time for the transseptal puncture was 0.44 (0.28-1.25) minutes, representing a mean of 21%±9% of the TFT used in these patients. There were no differences in the transseptal fluoroscopy times between the different VT substrates. The median fluoroscopy time for mapping and ablation in the 34 procedures with endocardial LV ablation was 0.43 (0.17-2.38) and 0.24 (0.08-1.73) minutes, respectively. These numbers represent 32%±17% and 24%±11%, respectively, of all the TFT consumed in these patients. Structural heart disease is defined as left ventricular hypertrophy >15 mm, LVEF <50%, valvulopathy of at least moderate grade, previous myocardial infarction, significant coronary artery disease, or the presence of a primary myocardial disease. BMI indicates body mass index; CRT, cardiac resynchronization therapy; ICD, implantable cardioverter-defibrillator; INR, international normalized ratio; IVT, ischemic ventricular tachycardia; LVEF, left ventricular ejection fraction; NIVT, nonischemic ventricular tachycardia; and NYHA, New York Heart Association.
VT Ablation With a Minimally Fluoroscopic Approach
Procedure-Related Complications and Ablation Outcomes
Only 1 procedure-related major complication occurred in 1 patient who developed cardiogenic shock after the ablation procedure. Intravenous inotropes were started without positive response, and the patient underwent implantation of an extracorporeal membrane oxygenation support. Five days after the ablation procedure, the patient finally died with refractory cardiogenic shock. Another patient developed an arterial pseudoaneurysm and required surgical repair with complete recovery and no long-term sequelae. Thus, the percentage of procedure-related complications in our series was 4.9%, none of them being related to the use of the new image integration module.
In the overall group, a mean of 31.1±16.1 and 20.4±11.6 radiofrequency lesions were applied to the endocardium and epicardium, respectively. Ablation resulted in noninducibility of all VTs in 27 patients (66%). In 9 patients (22%), a nonclinically relevant VT was still inducible at the end of the procedure. In 2 patients (5%), the clinical VT was still inducible at the end of the procedure in spite of endocardial and epicardial ablation, and an intramural VT substrate not accessible from the endocardial surface was suspected. Finally, in 3 patients (7%), no programmed ventricular stimulation was performed after ablation do to clinical instability.
During a mean follow-up of 217 (range, 21-542) days, 3 patients died because of progressive and drug refractory heart failure and 1 patient underwent implantation of a ventricular assist system. No patients died suddenly. Three patients (7.3%) had a VT recurrence and underwent a second VT ablation procedure.
Discussion
The use of the CARTOUNIVU module during VT ablation in a consecutive series of patients with structural heart disease resulted in low levels of radiation exposure. The median ED in the entire population sample was 2.15 (0.58-8.22) mSv, which is well below the 15 mSv considered the average patient dose during an atrial fibrillation ablation procedure. 12 Importantly, we included a high proportion of patients with NIVT in which an initial epicardial access was attempted. This resulted in higher fluoroscopy levels, but even considering this special subgroup, their median ED was 6.29 (1.57-10.11), still below the 15 mSv average.
The second principal finding of our study is that we were able to identify a subgroup of patients in which a near-zero fluoroscopy VT ablation procedure could be performed with <1 mSv of total ED. This was possible in 32% of the entire population sample, but this percentage increased 50% in patients with no epicardial access (14/28 procedures) who showed a median ED of 1.03 (0.35-2.13). Thus, patients with IVT who usually do not need an epicardial access during a first VT ablation procedure are the ones who will more frequently benefit from a near-zero fluoroscopy procedure using the CARTOUNIVU module. Of note, in the last 10 IVT patients included in the study, the mean ED was considerably further reduced to only 0.29 (0.19-0.54) mSv. Moreover, the mapping and ablation process consumed only 46% of the TFT in these 10 patients. Consequently, more than a half of the fluoroscopy dose was expended during the transseptal puncture. Importantly, these extraordinary low levels of radiation exposure were achieved with a high secure profile, with no single major or minor complications related to the use of the new image integration module. The safety of a nonfluoroscopic navigation approach is an important concern, and we think that the use of current technical innovations, such as catheters providing contact force information, is essential in this regard. A near-zero fluoroscopy approach has been previously described mostly during ablation of supraventricular arrhythmias, especially right atrial flutter, but had been never even conceived for complex arrhythmia ablations, such as scar-related VT ablation procedures. 13 Reduction of radiation exposure during electrophysiological procedures is desirable considering that different studies have pointed out a potential relationship between medical radiation exposure and an increased lifetime risk of malignancy. [14] [15] [16] [17] [18] [19] [20] Multiple innovations have been incorporated during the past years with this objective, including fluoroscopy system customization, remote robotic navigation systems, or integration of magnetic resonance imaging and CT scan images into the electroanatomic mapping system. 12, [21] [22] [23] [24] However, radiation exposure remains high during complex arrhythmia ablation procedures, such as atrial fibrillation ablation and, especially, VT ablation. Even in the most experienced hands, the mean fluoroscopy times reported in the largest VT ablation series are ≈26 to 46 minutes for patients with IVT and 39 to 48 minutes for patients with NIVT. 1, 2 Our results show that the use of the CARTOUNIVU module dramatically reduced the median fluoroscopy time to 2.53 (1.22-11.22) minutes for IVT patients and 8.51 (5.55-17.34) minutes for NIVT patients.
New image integration systems have recently demonstrated to significantly reduce fluoroscopy levels and doses, especially during atrial fibrillation ablation. [5] [6] [7] However, no systematic data in a large series of patients with structural heart disease and VT ablation have been yet published. Reents et al 8 recently reported a series of 23 patients undergoing VT ablation using the CARTOUNIVU module. However, only 11 patients of this series had scar-related VT. . 5 In the largest series published till date, our current results show a further reduction in fluoroscopy levels and doses even considering that we have included a less favorable population sample with a significant proportion of patients with an epicardial access. Of interest, the influence of the learning curve in the use of the CARTOUNIVU module should be taken into consideration because our results include the first cases performed with the CARTOUNIVU module in our institution. Increased experience with the image integration module resulted in further reduction of fluoroscopy times and the rest of radiation parameters. In fact, the first 20 VT ablation procedures of our series showed a median fluoroscopy time and doses comparable with the numbers reported by the abovementioned publications ( 2 ). Thus, it is possible to expect that after the initial learning curve, the percentage of IVT patients who may benefit from a near-zero fluoroscopy approach during VT ablation can be dramatically increased above the 43% reported in our entire population sample.
On the other hand, we also evaluated the utility of the CARTOUNIVU module in patients with epicardial access to integrate the real-time coronary angiogram performed before epicardial ablation into the electroanatomic mapping system. Beyond the reduction in radiation exposure, this is the second most important utility of this image integration tool. Injury of the coronary arteries is one of the principal potential complications during epicardial VT ablation. Thus, the performance of coronary angiography is mandatory in this setting. Traditionally, the coronary angiogram was obtained during the procedure with the ablation catheter located at the desired radiofrequency application site to evaluate the proximity of the coronary vasculature to the region of interest. However, this approach has evident limitations. First, the coronary angiography cannot be seen on top of the electroanatomic voltage map making difficult to exactly locate the position of the ablation catheter tip with respect to the coronary artery course and to the epicardial substrate. On the other hand, considering that linear or substrate-guided ablation is a frequent strategy in patients with nonischemic dilated cardiomyopathy, the initial position of the ablation catheter during the coronary angiogram cannot be considered an accurate safety measure to avoid coronary vessel injury taking into account that multiple different sites will be targeted during VT ablation. More recently, image integration tools have been developed aiming for coronary artery visualization based on the information collected from CT scans. 25, 26 The reconstruction of the cardiac chambers and coronary vessels obtained with these image techniques can be integrated into the electroanatomic mapping system. However, the CT scan is usually performed before the ablation procedure, and differences in chamber dimensions and geometry changes related to cardiac rhythm or chamber filling variations may hinder the accuracy of the preprocedural CT scan information. In our series, the epicardial VT substrate could be safely and successfully ablated with a direct and real-time visualization of the coronary arteries within the epicardial voltage map, and no single complication related to epicardial ablation occurred.
Limitations
This is an observational study, and potentially confounding factors may have influenced our results and cannot be completely excluded. We report the experience of a single center, and thus, the sample size is small. On the basis of our results, further studies, including a larger population sample, should help to confirm our initial observations. Finally, our analysis did not account for multiple ablations per patient, but those were <10% of total observations (3 patients).
Conclusions
The use of the CARTOUNIVU module during VT ablation in patients with structural heart disease resulted in low levels of radiation exposure. Patients with IVT and endocardial LV ablation only were the most likely to benefit from this image integration tool, with 48% of these patients with a near-zero fluoroscopy procedure (ED≤1 mSv). In patients with an epicardial VT circuit, the CARTOUNIVU module also served to integrate the real-time coronarography into the electroanatomical mapping system, thus guiding epicardial ablation and preventing coronary artery injury.
